United Therapeutics | UTHR - Cost Of Sales


United Therapeutics reported $133.4M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Amarin USD 26.05M 1.41M Dec/2025
Ardelyx USD 10.85M 6.87M Dec/2025
Baxter International USD 1.81B 587M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
BioCryst Pharmaceuticals USD 9.52M 7.34M Dec/2025
Biogen USD 797.5M 302M Mar/2026
BioMarin Pharmaceutical USD 199.48M 37.93M Mar/2026
Emergent BioSolutions USD 381.2M 226.1M Jun/2023
Esperion Therapeutics USD 27.85M 13.43M Dec/2025
Gilead Sciences USD 1.44B 174M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Halozyme Therapeutics USD 108.75M 6.6M Mar/2026
Insmed USD 49.5M 3.34M Mar/2026
Ionis Pharmaceuticals USD 3M 5M Mar/2026
J&J USD 8.07B 103M Mar/2026
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Moderna USD 955M 503M Mar/2026
Omeros USD 33.16M 18.52M Jun/2024
Pfizer USD 4.59B 1.7B Mar/2026
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 109.46M 289.93M Mar/2026
Teva Pharmaceutical Industries USD 2.01B 46M Mar/2026
United Therapeutics USD 133.4M 341.3M Mar/2026
Vertex Pharmaceuticals USD 392.8M 73.2M Mar/2026